7/5/2022Biotech Winter in China Set to Adjust Valuation and Prompt Consolidati...

7/1/2022PharmaDJ: MSD and Turning Point Turn to China for Big Deals in May

6/28/2022CDE Solicits Comments on the Draft Technical Guidelines for Clinical E...

6/24/2022Huadong and Julphar Announce Strategic Cooperation of Liraglutide in M...

6/24/2022At ASCO 2022, Chinese Biotech Firms Deliver Rosy Data On PD-(L)1, Cell...

6/22/2022China's Mental-health Crisis Is Getting Worse (Economist)

6/21/2022China's May Fundraising Indicates Interest in Early-stage Biotech

6/16/2022May Approvals Spotlight the Rise of Pediatric Drugs under Policy Suppo...

6/9/2022OnCusp and Multitude Enter into an Ex-China Licensing Agreement for a ...

6/7/2022How Shanghai Kept Clinical Trials Going During Lockdown (PharmaDJ)

5/26/2022April Licensing Trends Show Chinese Biotechs Expanding Beyond Oncology...

5/20/2022Couple Plead Guilty to Smuggling and Fraud Charges After Sending ‘mRN...

5/19/2022Pediatric Drug Development A New Investment Area in China (PharmaDJ's ...

5/16/2022Pfizer Leads April Approvals in China with Two JAK Inhibitors (PharmaD...

5/13/2022Green Valley Aborts Trial of Its Alzheimer's Drug amid Fundraisng and ...

5/2/2022Former GSK Scientist Convicted of Stealing Trade Secrets To Benefit Ch...

4/29/2022Adagene-Sanofi's $2.5B Deal Tops March Deals in China (PharmaDJ)

4/26/2022China Clears Homegrown PD-1 Inhibitors for Solid Tumors (PharmaDJ's Ch...

4/26/2022Arrowhead and Vivo Capital Launch JV Aimed at Greater China Market

4/21/2022CDE Issues the Technical Guidelines for Adverse Drug Reaction Data Sum...

4/20/2022PharmaDJ's China Biotech Fundraising Tracker: March 2022

4/16/2022Opportunities and Challenges in China for Developing Oncology Drugs fo...

4/12/2022Chinese Pharma Foreign Trade Up 1.9% in 2021 with Sharply Surging West...

4/12/2022Pfizer Wins Chinese Approval of JAK1 Inhibitor Abrocitinib for moderat...

4/11/2022India Hopes 'Pharma City' Will Break China's Grip on Industry

4/1/2022CASI Pharma Added to SEC List of Firms Facing Possible U.S. Delisting

3/31/2022NMPA Publishes 2021 Annual Report for Adverse Drug Reaction Monitoring

3/31/2022More JAK Therapies for Atopic Dermatitis Expected in China (PharmaDJ)

3/24/2022What Could Happen Next for U.S.-listed Chinese Stocks? (PharmaDJ)

3/22/2022PharmaDJ's China Deals Tracker: February 2022

Page:6/26 Total number of articles:751: [First][<<] [4] [5] [6] [7] [8] [>>] [End]